Cite
MLA Citation
Olga-Demetra Biziotis et al.. “40 Canagliflozin, a New Anti-Diabetic Agent Targeting Cellular Metabolism, Suppresses Survival and Enhances the Response of Non-Small Cell Lung Cancer (NSCLC) to Radiotherapy.” Radiotherapy and oncology, vol. 139, n.d., pp. S20–. http://access.bl.uk/ark:/81055/vdc_100093289928.0x000028